ENTRY       K07187                      KO
NAME        IRS2
DEFINITION  insulin receptor substrate 2
PATHWAY     ko04022  cGMP-PKG signaling pathway
            ko04068  FoxO signaling pathway
            ko04152  AMPK signaling pathway
            ko04910  Insulin signaling pathway
            ko04920  Adipocytokine signaling pathway
            ko04930  Type II diabetes mellitus
            ko04932  Non-alcoholic fatty liver disease (NAFLD)
            ko05206  MicroRNAs in cancer
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04068 FoxO signaling pathway
                K07187  IRS2; insulin receptor substrate 2
               04022 cGMP - PKG signaling pathway
                K07187  IRS2; insulin receptor substrate 2
               04152 AMPK signaling pathway
                K07187  IRS2; insulin receptor substrate 2
             Organismal Systems
              Endocrine system
               04910 Insulin signaling pathway
                K07187  IRS2; insulin receptor substrate 2
               04920 Adipocytokine signaling pathway
                K07187  IRS2; insulin receptor substrate 2
             Human Diseases
              Cancers
               05206 MicroRNAs in cancer
                K07187  IRS2; insulin receptor substrate 2
              Endocrine and metabolic diseases
               04930 Type II diabetes mellitus
                K07187  IRS2; insulin receptor substrate 2
               04932 Non-alcoholic fatty liver disease (NAFLD)
                K07187  IRS2; insulin receptor substrate 2
GENES       HSA: 8660(IRS2)
            PTR: 452657(IRS2)
            PPS: 100982406(IRS2)
            GGO: 101127585(IRS2)
            MCC: 698536(IRS2)
            MCF: 102122241(IRS2)
            MMU: 384783(Irs2)
            RNO: 29376(Irs2)
            CGE: 100771848(Irs2)
            HGL: 101719081(Irs2)
            TUP: 102497747(IRS2)
            CFA: 485548(IRS2)
            AML: 100477685(IRS2)
            FCA: 101095791(IRS2)
            BTA: 100300012(IRS2)
            BACU: 103005810(IRS2)
            LVE: 103088704(IRS2)
            ECB: 100146249(IRS2)
            MYB: 102249810(IRS2)
            MYD: 102753060(IRS2)
            PALE: 102898575(IRS2)
            MDO: 100023831(IRS2) 100025395
            SHR: 100924829(IRS2) 100931354
            GGA: 422347 428017(IRS2)
            MGP: 100540702 100548754
            TGU: 100220894(IRS2) 100223674
            FAB: 101807499 101814066(IRS2)
            PHI: 102103569 102111858(IRS2)
            APLA: 101801905 101804723(IRS2)
            FPG: 101918515 101924402(IRS2)
            FCH: 102046894(IRS2) 102052095
            CLV: 102089452(IRS2) 102090441
            ASN: 102374791(IRS2) 102382907
            AMJ: 102558545 102565350(IRS2)
            PSS: 102457842
            CMY: 102934421(IRS2)
            PBI: 103051591(IRS2) 103052062
            XLA: 399388(irs4) 495836(irs2)
            XTR: 100196925(irs4) 100498409
            DRE: 100329897(irs4a) 393285 572001(irs2)
            TRU: 101069496 101074788 101076043
            MZE: 101465453 101468614 101476715 101482705
            OLA: 101162408 101169068 101174984
            XMA: 102226863 102227153 102236425
            LCM: 102364884(IRS2) 102366705
            CMK: 103178654(irs2) 103179604
            CQU: CpipJ_CPIJ005269
            ISC: IscW_ISCW021008
            TAD: TRIADDRAFT_28050
REFERENCE   PMID:11114102
  AUTHORS   Giovannone B, Scaldaferri ML, Federici M, Porzio O, Lauro D, Fusco A, Sbraccia P, Borboni P, Lauro R, Sesti G
  TITLE     Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential.
  JOURNAL   Diabetes Metab Res Rev 16:434-41 (2000)
///
